Stock-Based Compensation: The estimated market value of stock options, warrants and other stock-based compensation given to employees and/or vendors.
GeneDx Holdings Corp. (WGS) had Stock-Based Compensation of $32.16M for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
$427.54M |
|
$-21.02M |
|
$129.37M |
|
$298.17M |
|
$440.62M |
|
$-13.08M |
|
$-8.06M |
|
$-21.14M |
|
$-21.14M |
|
$-21.02M |
|
$-21.02M |
|
$-21.02M |
|
$-21.02M |
|
$-13.08M |
|
$12.15M |
|
28.64M |
|
28.64M |
|
$-0.73 |
|
$-0.73 |
|
| Balance Sheet Financials | |
$268.29M |
|
$45.69M |
|
$255.42M |
|
$523.71M |
|
$108.91M |
|
$48.18M |
|
$106.62M |
|
$215.53M |
|
$308.18M |
|
$126.18M |
|
$308.18M |
|
29.25M |
|
| Cash Flow Statement Financials | |
$33.28M |
|
$-61.52M |
|
$48.02M |
|
$86.20M |
|
$105.99M |
|
$19.79M |
|
|
Stock-Based Compensation |
$32.16M |
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.46 |
|
-- |
|
-- |
|
0.14 |
|
0.16 |
|
69.74% |
|
-3.06% |
|
-3.06% |
|
2.84% |
|
-4.94% |
|
-4.92% |
|
$14.26M |
|
-- |
|
-- |
|
-- |
|
0.82 |
|
9.27 |
|
5.75 |
|
63.49 |
|
-6.82% |
|
-16.66% |
|
-4.01% |
|
-5.90% |
|
$10.54 |
|
$0.50 |
|
$1.16 |
|